Status:

COMPLETED

Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

Chestnut Hill Health System

Conditions:

Hypercholesterolemia

Statin-Associated Myopathy

Eligibility:

All Genders

21-80 years

Phase:

PHASE2

Brief Summary

This study will examine the effect of red yeast rice extract compared to pravastatin on muscle related complaints in individuals with high cholesterol who have previously been unable to tolerate stati...

Detailed Description

20 million Americans are actively treated with statins at an annual cost of 16 billion dollars. Statins are effective therapeutic agents for reducing LDL cholesterol and have documented effectiveness....

Eligibility Criteria

Inclusion

  • Subject reports stopping at least one statin drug due to complaints of muscle pain or weakness which his/her physician thinks was attributable to the drug.
  • Subject has never taken pravastatin.
  • Subject willing to remain off the dietary supplements CoQ10, L-carnitine, fish oil, policosanol, and guggulipid, garlic, and phytosterols in margarines (e.g. Benecol, Promise activ), milk or cereal products, for one month prior to the trial and for the duration of the trial.

Exclusion

  • A history of muscle damage (CK\>1000 IU) on statin therapy.
  • A history of generalized chronic pain such as fibromyalgia, or generalized arthritis.
  • Any active cardiac problem including chest pain, angina, heart attack, bypass surgery, angioplasty/stent or unstable angina/acute coronary syndrome within the past 6 months.
  • Taking other lipid lowering drugs including: ezetimibe, gemfibrozil, niacin, fibrates or bile acid sequestrants.
  • Triglyceride level more than 400 mg/dl.
  • Taking weight loss medication including orlistat, sibutramine, diethylpropion, phendimetrazine, phentermine.
  • Taking pain medication or systemic steroids on a chronic basis.

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2008

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT00639223

Start Date

January 1 2008

End Date

October 1 2008

Last Update

January 18 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chestnut Hill Hospital

Philadelphia, Pennsylvania, United States, 19118